ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke – Medical Marijuana Program Connection

SASKATOON, Saskatchewan–(BUSINESS WIRE)– #HealthcareInnovations–ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced the appointment of Hance Clarke, MD, PhD, FRCPC to ZYUS Life Sciences Inc.’s Clinical Advisory Committee. Dr. Clarke’s extensive background in healthcare and pain management aligns seamlessly with the committee’s mission to pro

Source link

• SEO Powered Content & PR Distribution. Get Amplified Today.
• PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
• PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
• PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
• PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
• Source: https://mmpconnect.com/zyus-strengthens-expertise-of-clinical-advisory-committee-with-the-appointment-of-dr-hance-clarke/?utm_source=rss&utm_medium=rss&utm_campaign=zyus-strengthens-expertise-of-clinical-advisory-committee-with-the-appointment-of-dr-hance-clarke